Reed Jobs

Reed Paul Jobs is an American venture capitalist and the founder of Yosemite Venture Fund, a San Francisco-based firm dedicated to cancer drug discovery and immunotherapy. As the youngest son of Apple co-founder Steve Jobs and philanthropist Laurene Powell Jobs, he carries a name synonymous with innovation, yet he has deliberately built his own identity in the world of healthcare investing.

His fund, which manages over $1 billion in assets, operates on a hybrid model that blends traditional venture capital with philanthropic grants. This approach reflects his conviction that technology can fundamentally transform how cancer is treated. In January 2026, Yosemite raised an additional $200 million, signaling strong confidence in his vision.

Reed is known for his low-key public presence, preferring to let his work speak for itself. He rarely discusses his family legacy in interviews, instead steering conversations toward the scientific and technological challenges of oncology. His commitment to making cancer non-lethal within a lifetime has earned him respect in both the biotech and investment communities. [edit]

Reed grew up in Palo Alto, California, in a household where technology and social impact were daily topics. His father, Steve Jobs, co-founded Apple, while his mother, Laurene Powell Jobs, ran Emerson Collective, a social impact organization. He was the third of four children, with older siblings Lisa Brennan-Jobs and Erin Jobs, and a younger sister, Eve Jobs.

His childhood was marked by his father's battle with pancreatic cancer, which ultimately claimed Steve's life on October 5, 2011, when Reed was just 12 years old. This loss left a profound mark on him, steering his interests toward medicine and science. Despite the family's prominence, Reed attended Homestead High School in Cupertino, where he was known as a bright but unassuming student.

He enrolled at Stanford University, where he chose to study history rather than computer science or engineering. This decision reflected his broad intellectual curiosity and a desire to understand the human context behind technological change. After graduating in 2013, he took a job in healthcare investment banking, a field that combined his interest in medicine with financial acumen. That role gave him his first close look at the business of healthcare and set the stage for his later career in venture capital. [edit]

Reed's career in venture capital began in earnest in 2015 when he joined Emerson Collective, his mother's organization, as a managing director. There, he focused on health-related investments, gaining experience that would prove invaluable. In 2018, he started conceptualizing his own fund, and in August 2023, he officially launched Yosemite Venture Fund in San Francisco.

The fund's mission is narrow but ambitious: to invest in late-stage academic research and early-stage startups working on cancer drug discovery and immunotherapy. By 2024, Yosemite had secured over $500 million in initial commitments. In 2025, the fund made its first major investment in a cancer immunotherapy company. A year later, in January 2026, Yosemite raised an additional $200 million, bringing its total assets under management past the $1 billion mark.

Yosemite has also participated in high-profile financing rounds, including a $3.75 billion round for HistoSonics in June 2026. Reed's approach combines grants with equity investments, allowing the fund to support research that might otherwise struggle to attract traditional venture capital. In May 2026, he announced plans to expand into the UK cancer research sector, and by August of that year, he was publicly commenting on how pandemic-era office prices had fueled San Francisco's AI tech boom. [edit]

Reed Jobs is perceived as a mission-driven investor who deliberately distances himself from his father's towering legacy. He avoids tabloid attention and rarely gives interviews, but when he does, he focuses on cancer research and healthcare innovation. Media portrayals often highlight his humility and his preference for substance over spectacle. Within the venture capital and biotech communities, he is respected for his strategic vision and ethical approach to investing. There is no formal fanbase, but he has become a respected figure among those interested in the intersection of technology and medicine. [edit]

Reed Jobs does not currently hold a placement in the iFANN Global Top 1,000 or any scope-specific top-100 list, a status confirmed by the August 2026 evaluation of his public footprint. While his name carries immediate recognition due to his lineage, his professional trajectory as a venture capitalist focused on oncology has kept him outside the metrics that drive celebrity rankings. The iFANN framework assesses global consumption signals and media coverage to determine standing, and in this instance, the data indicates a lack of the widespread cultural saturation required for a ranked position. His presence is defined by specialized influence within the biotech and investment sectors rather than broad public fame.

There is no documented fandom associated with Reed Jobs, nor is there an official name for any group of admirers. Unlike entertainers who inspire organized fan campaigns, birthday tributes, or viral social media movements, Jobs maintains a deliberate distance from the spectacle of celebrity culture. His audience consists primarily of industry professionals, researchers, and those following developments in cancer therapy innovation. No fan-funded projects, dedicated rituals, or specific community hashtags have been recorded. The absence of a formal fanbase reflects his preference for substance over spectacle and his choice to operate away from the public eye, ensuring that attention remains focused on his work at Yosemite Venture Fund rather than on personal adoration.[edit]

Despite his famous surname, Reed rarely references his father in public statements, preferring to be judged on his own merits. He chose to study history at Stanford rather than computer science, a decision that surprised many given his family background. Yosemite Venture Fund operates as a hybrid model, blending venture capital with grant-making, a structure that is uncommon in traditional VC firms. Reed has a minimal digital footprint, with no verified social media accounts under his own name. He once noted that he would rather talk about curing cancer than his last name, a sentiment that has defined his public persona.

A significant chapter in his life involves the loss of his father, Steve Jobs, to cancer, a fact that deeply informs his mission to make the disease nonlethal. In August 2023, he launched Yosemite Venture Fund with the explicit goal of transforming cancer treatment through technology. By January 2026, the firm successfully raised an additional $200 million, reinforcing its commitment to high-impact healthcare investments. These milestones are widely cited in biographical profiles as the defining moments of his career, distinguishing his legacy from the tech innovations of his parents.[edit]

Reed is the youngest son of Steve Jobs and Laurene Powell Jobs. His father passed away from pancreatic cancer in 2011, an event that deeply influenced Reed's career path. His mother, Laurene, is the founder of Emerson Collective, a social impact organization. He has three siblings: Lisa Brennan-Jobs, an author, Erin Jobs, and Eve Jobs, a model. The family has remained close-knit, with Laurene often hosting gatherings at their Palo Alto home. Reed has no public record of a spouse or children, and he keeps his personal life private. [edit]

Reed Jobs is associated with his mother Laurene Powell Jobs, founder of Emerson Collective, and his late father Steve Jobs, co-founder of Apple. His siblings include Lisa Brennan-Jobs, Erin Jobs, and Eve Jobs. In the venture capital world, he works with founders and executives at Yosemite portfolio companies, such as the leadership team at HistoSonics. [edit]

Reed Jobs has kept his personal life out of the public eye. As of 2026, there are no confirmed reports of any romantic relationships, marriages, or children. He has never been publicly linked to any partner, and he does not discuss his personal life in interviews. His focus appears to be entirely on his professional mission.

Given his private nature, it is possible that he has had relationships that were not made public, but no credible sources have documented any. As of mid-2026, he is widely reported to be single. [edit]

iFANN currently estimates Reed Jobs' net worth at $100 Million. This figure is derived from his stake in Yosemite Venture Fund, his salary and carried interest from managing the fund, and his inheritance from the Jobs family estate. While the exact breakdown is private, his role as managing partner of a fund with over $1 billion in assets likely generates significant income through management fees and performance-based compensation. His net worth has grown steadily since founding Yosemite in 2023, as the fund has attracted substantial capital commitments. The $200 million raise in January 2026 and successful investments, such as the HistoSonics round, have bolstered his financial standing. Additionally, he received an inheritance from his father's estate, which is managed separately and estimated at over $10 billion, though that figure is not included in his personal net worth. Reed's income sources are diversified, including investment returns from his personal portfolio and potential speaking fees, though he rarely takes public engagements. His financial trajectory is closely tied to the performance of Yosemite's portfolio, which is focused on high-growth cancer therapy startups.[edit]